_id
69130518ccc777a4e85d7a8f
Ticker
IYXI
Name
Inyx Inc
Exchange
OTCCE
Address
825 Third Avenue, New York, NY, United States, 10022
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
Description
Inyx, Inc., through its wholly-owned subsidiaries, operates as a specialty pharmaceutical company in the United States, Canada, and Europe. It develops and manufactures prescription and over-the-counter pharmaceutical products. The company manufactures hydrocarbon aerosols, a delivery system for dermatological and topical drug applications; metered dose inhalers that are used for respiratory conditions; dry powdered inhalers used for respiratory ailments; metered dose nasal and throat pumps, and sprays; and sterile salines and injectables. It focuses on research and development activities on inhalation-therapy drug delivery devices and inhalation methods, and generic prescription, and over-the-counter aerosol pharmaceutical products for respiratory, allergy, dermatological, and topical and cardiovascular applications. The company's proprietary products under development include generic versions of nonchlorofluorocarbon or hydrofluoroalkane single molecule and combination drug respiratory inhalants, nonCFC propelled oral sprays for cardiovascular ailments, wound irrigation, and cleansing sprays that utilize novel barrier technologies, and anti-inflammatory nasal pumps. It also provides specialty pharmaceutical development and manufacturing consulting services to the international healthcare market. The company was incorporated in 2000 and is based in New York, New York.
Last Close
0.0001
Volume
-
Current Price
0.0001
Change
0
Last Updated
2026-01-04T15:34:12.411Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
26553
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2006-09-30
Revenue
18006000
Cost Of Revenue
10593000
Gross Profit
7413000
Operating Expenses
22741000
Operating Income
-4735000
Interest Expense
2708000
Pretax Income
-9743000
Net Income
-9743000
Eps
-
Dividends Per Share
0
Shares Outstanding
0
Income Tax Expense
0
EBITDA
-
Operating Margin
-26.29678995890259
Total Other Income Expense Net
-5008000
Cash
1518000
Short Term Investments
0
Receivables
22790000
Inventories
12117000
Total Current Assets
39687000
Property Plant Equipment
41528000
Total Assets
114494000
Payables
13966000
Short Term Debt
0
Long Term Debt
0
Total Liabilities
153357000
Equity
-38863000
Bs_currency_symbol
USD
Depreciation
2051000
Change In Working Capital
-
Cash From Operations
-8879000
Capital Expenditures
3067000
Cash From Investing
-13103000
Cash From Financing
22679000
Net Change In Cash
174000
Cf_currency_symbol
USD
PE
-
PB
0
ROE
25.070118107197075
ROA
-8.509616224430975
FCF
-11946000
Fcf Percent
-0.6634455181606131
Piotroski FScore
1
Health Score
37
Deep Value Investing Score
2
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
6.3
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
3
Net Net Investing Score
2
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2006-09-30
Quarters > 0 > income Statement > revenue
18006000
Quarters > 0 > income Statement > cost Of Revenue
10593000
Quarters > 0 > income Statement > gross Profit
7413000
Quarters > 0 > income Statement > operating Expenses
22741000
Quarters > 0 > income Statement > operating Income
-4735000
Quarters > 0 > income Statement > interest Expense
2708000
Quarters > 0 > income Statement > pretax Income
-9743000
Quarters > 0 > income Statement > net Income
-9743000
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
0
Quarters > 0 > income Statement > shares Outstanding
0
Quarters > 0 > income Statement > income Tax Expense
0
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-26.29678995890259
Quarters > 0 > income Statement > total Other Income Expense Net
-5008000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
1518000
Quarters > 0 > balance Sheet > short Term Investments
0
Quarters > 0 > balance Sheet > receivables
22790000
Quarters > 0 > balance Sheet > inventories
12117000
Quarters > 0 > balance Sheet > total Current Assets
39687000
Quarters > 0 > balance Sheet > property Plant Equipment
41528000
Quarters > 0 > balance Sheet > total Assets
114494000
Quarters > 0 > balance Sheet > payables
13966000
Quarters > 0 > balance Sheet > short Term Debt
0
Quarters > 0 > balance Sheet > long Term Debt
0
Quarters > 0 > balance Sheet > total Liabilities
153357000
Quarters > 0 > balance Sheet > equity
-38863000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-9743000
Quarters > 0 > cash Flow > depreciation
2051000
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-8879000
Quarters > 0 > cash Flow > capital Expenditures
3067000
Quarters > 0 > cash Flow > cash From Investing
-13103000
Quarters > 0 > cash Flow > cash From Financing
22679000
Quarters > 0 > cash Flow > net Change In Cash
174000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
0
Quarters > 0 > ratios > ROE
25.070118107197075
Quarters > 0 > ratios > ROA
-8.509616224430975
Quarters > 0 > ratios > FCF
-11946000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.6634455181606131
Quarters > 0 > health Score
37
Quarters > 1 > quarter
2006-06-30
Quarters > 1 > income Statement > revenue
20142000
Quarters > 1 > income Statement > cost Of Revenue
12528000
Quarters > 1 > income Statement > gross Profit
7614000
Quarters > 1 > income Statement > operating Expenses
25857000
Quarters > 1 > income Statement > operating Income
-5715000
Quarters > 1 > income Statement > interest Expense
2430000
Quarters > 1 > income Statement > pretax Income
-9845000
Quarters > 1 > income Statement > net Income
-9845000
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
0
Quarters > 1 > income Statement > shares Outstanding
0
Quarters > 1 > income Statement > income Tax Expense
0
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-28.37354781054513
Quarters > 1 > income Statement > total Other Income Expense Net
-4130000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
1344000
Quarters > 1 > balance Sheet > short Term Investments
0
Quarters > 1 > balance Sheet > receivables
23189000
Quarters > 1 > balance Sheet > inventories
9790000
Quarters > 1 > balance Sheet > total Current Assets
37734000
Quarters > 1 > balance Sheet > property Plant Equipment
41440000
Quarters > 1 > balance Sheet > total Assets
100543000
Quarters > 1 > balance Sheet > payables
14368000
Quarters > 1 > balance Sheet > short Term Debt
0
Quarters > 1 > balance Sheet > long Term Debt
41760000
Quarters > 1 > balance Sheet > total Liabilities
134117000
Quarters > 1 > balance Sheet > equity
-33574000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-9845000
Quarters > 1 > cash Flow > depreciation
1981000
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-3824000
Quarters > 1 > cash Flow > capital Expenditures
1074000
Quarters > 1 > cash Flow > cash From Investing
-3421000
Quarters > 1 > cash Flow > cash From Financing
5433000
Quarters > 1 > cash Flow > net Change In Cash
-244000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
0
Quarters > 1 > ratios > ROE
29.323285875975458
Quarters > 1 > ratios > ROA
-9.791830361139015
Quarters > 1 > ratios > FCF
-4898000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.24317346837454076
Quarters > 1 > health Score
37
Quarters > 2 > quarter
2006-03-31
Quarters > 2 > income Statement > revenue
21412000
Quarters > 2 > income Statement > cost Of Revenue
13111000
Quarters > 2 > income Statement > gross Profit
8301000
Quarters > 2 > income Statement > operating Expenses
21715000
Quarters > 2 > income Statement > operating Income
-303000
Quarters > 2 > income Statement > interest Expense
2290000
Quarters > 2 > income Statement > pretax Income
-2593000
Quarters > 2 > income Statement > net Income
-2593000
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
0
Quarters > 2 > income Statement > shares Outstanding
0
Quarters > 2 > income Statement > income Tax Expense
0
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-1.4150943396226416
Quarters > 2 > income Statement > total Other Income Expense Net
-2290000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
1588000
Quarters > 2 > balance Sheet > short Term Investments
0
Quarters > 2 > balance Sheet > receivables
22450000
Quarters > 2 > balance Sheet > inventories
10974000
Quarters > 2 > balance Sheet > total Current Assets
37731000
Quarters > 2 > balance Sheet > property Plant Equipment
39184000
Quarters > 2 > balance Sheet > total Assets
97465000
Quarters > 2 > balance Sheet > payables
14523000
Quarters > 2 > balance Sheet > short Term Debt
0
Quarters > 2 > balance Sheet > long Term Debt
44185000
Quarters > 2 > balance Sheet > total Liabilities
125236000
Quarters > 2 > balance Sheet > equity
-27771000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-2593000
Quarters > 2 > cash Flow > depreciation
1950000
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
587000
Quarters > 2 > cash Flow > capital Expenditures
1158000
Quarters > 2 > cash Flow > cash From Investing
-3845000
Quarters > 2 > cash Flow > cash From Financing
3446000
Quarters > 2 > cash Flow > net Change In Cash
565000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
0
Quarters > 2 > ratios > ROE
9.337078247092292
Quarters > 2 > ratios > ROA
-2.660442210024111
Quarters > 2 > ratios > FCF
-571000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-0.02666728937044648
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2005-12-31
Quarters > 3 > income Statement > revenue
25479000
Quarters > 3 > income Statement > cost Of Revenue
18623000
Quarters > 3 > income Statement > gross Profit
6856000
Quarters > 3 > income Statement > operating Expenses
36645000
Quarters > 3 > income Statement > operating Income
-11166000
Quarters > 3 > income Statement > interest Expense
2163000
Quarters > 3 > income Statement > pretax Income
-14029000
Quarters > 3 > income Statement > net Income
-14946000
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
0
Quarters > 3 > income Statement > shares Outstanding
0
Quarters > 3 > income Statement > income Tax Expense
0
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-43.82432591545979
Quarters > 3 > income Statement > total Other Income Expense Net
-2863000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
1023000
Quarters > 3 > balance Sheet > short Term Investments
0
Quarters > 3 > balance Sheet > receivables
20137000
Quarters > 3 > balance Sheet > inventories
11331000
Quarters > 3 > balance Sheet > total Current Assets
34725000
Quarters > 3 > balance Sheet > property Plant Equipment
39240000
Quarters > 3 > balance Sheet > total Assets
92153000
Quarters > 3 > balance Sheet > payables
11589000
Quarters > 3 > balance Sheet > short Term Debt
0
Quarters > 3 > balance Sheet > long Term Debt
46236000
Quarters > 3 > balance Sheet > total Liabilities
122553000
Quarters > 3 > balance Sheet > equity
-30400000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-14946000
Quarters > 3 > cash Flow > depreciation
2206000
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-7373000
Quarters > 3 > cash Flow > capital Expenditures
1213000
Quarters > 3 > cash Flow > cash From Investing
47937000
Quarters > 3 > cash Flow > cash From Financing
-41459000
Quarters > 3 > cash Flow > net Change In Cash
-3197000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
0
Quarters > 3 > ratios > ROE
49.16447368421053
Quarters > 3 > ratios > ROA
-16.218679804238604
Quarters > 3 > ratios > FCF
-8586000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.3369833980925468
Quarters > 3 > health Score
37
Annuals > 0 > quarter
2005-12-31
Annuals > 0 > income Statement > revenue
49565000
Annuals > 0 > income Statement > cost Of Revenue
34859000
Annuals > 0 > income Statement > gross Profit
14706000
Annuals > 0 > income Statement > operating Expenses
67515000
Annuals > 0 > income Statement > operating Income
-17950000
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-31009000
Annuals > 0 > income Statement > net Income
-31009000
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
0
Annuals > 0 > income Statement > shares Outstanding
0
Annuals > 0 > income Statement > income Tax Expense
0
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-36.21507111873298
Annuals > 0 > income Statement > total Other Income Expense Net
-13059000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
1023000
Annuals > 0 > balance Sheet > short Term Investments
0
Annuals > 0 > balance Sheet > receivables
20137000
Annuals > 0 > balance Sheet > inventories
11331000
Annuals > 0 > balance Sheet > total Current Assets
34725000
Annuals > 0 > balance Sheet > property Plant Equipment
39240000
Annuals > 0 > balance Sheet > total Assets
92153000
Annuals > 0 > balance Sheet > payables
11589000
Annuals > 0 > balance Sheet > short Term Debt
0
Annuals > 0 > balance Sheet > long Term Debt
46236000
Annuals > 0 > balance Sheet > total Liabilities
122553000
Annuals > 0 > balance Sheet > equity
-30400000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-31009000
Annuals > 0 > cash Flow > depreciation
4670000
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-17867000
Annuals > 0 > cash Flow > capital Expenditures
2193000
Annuals > 0 > cash Flow > cash From Investing
-4102000
Annuals > 0 > cash Flow > cash From Financing
25614000
Annuals > 0 > cash Flow > net Change In Cash
687000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
0
Annuals > 0 > ratios > ROE
102.0032894736842
Annuals > 0 > ratios > ROA
-33.64947424392044
Annuals > 0 > ratios > FCF
-20060000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.40472107333804097
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2004-12-31
Annuals > 1 > income Statement > revenue
15699000
Annuals > 1 > income Statement > cost Of Revenue
14316000
Annuals > 1 > income Statement > gross Profit
1383000
Annuals > 1 > income Statement > operating Expenses
27938000
Annuals > 1 > income Statement > operating Income
-12239000
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-15609000
Annuals > 1 > income Statement > net Income
-16942000
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
0
Annuals > 1 > income Statement > shares Outstanding
0
Annuals > 1 > income Statement > income Tax Expense
1333000
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-77.96037964201543
Annuals > 1 > income Statement > total Other Income Expense Net
-3370000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
336000
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
1697000
Annuals > 1 > balance Sheet > inventories
1520000
Annuals > 1 > balance Sheet > total Current Assets
4149000
Annuals > 1 > balance Sheet > property Plant Equipment
4689000
Annuals > 1 > balance Sheet > total Assets
14755000
Annuals > 1 > balance Sheet > payables
4091000
Annuals > 1 > balance Sheet > short Term Debt
0
Annuals > 1 > balance Sheet > long Term Debt
113000
Annuals > 1 > balance Sheet > total Liabilities
20620000
Annuals > 1 > balance Sheet > equity
-5865000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-16942000
Annuals > 1 > cash Flow > depreciation
785000
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-9019000
Annuals > 1 > cash Flow > capital Expenditures
1641000
Annuals > 1 > cash Flow > cash From Investing
-1736000
Annuals > 1 > cash Flow > cash From Financing
10501000
Annuals > 1 > cash Flow > net Change In Cash
-460000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
0
Annuals > 1 > ratios > ROE
288.8661551577153
Annuals > 1 > ratios > ROA
-114.82209420535412
Annuals > 1 > ratios > FCF
-10660000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-0.6790241416650742
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2003-12-31
Annuals > 2 > income Statement > revenue
15495000
Annuals > 2 > income Statement > cost Of Revenue
12510000
Annuals > 2 > income Statement > gross Profit
2985000
Annuals > 2 > income Statement > operating Expenses
24043000
Annuals > 2 > income Statement > operating Income
-8548000
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-15036000
Annuals > 2 > income Statement > net Income
-14300000
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
0
Annuals > 2 > income Statement > shares Outstanding
0
Annuals > 2 > income Statement > income Tax Expense
-1294000
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-55.16618263956114
Annuals > 2 > income Statement > total Other Income Expense Net
-6488000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
796000
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
3395000
Annuals > 2 > balance Sheet > inventories
1089000
Annuals > 2 > balance Sheet > total Current Assets
6369000
Annuals > 2 > balance Sheet > property Plant Equipment
5183000
Annuals > 2 > balance Sheet > total Assets
15490000
Annuals > 2 > balance Sheet > payables
2178000
Annuals > 2 > balance Sheet > short Term Debt
0
Annuals > 2 > balance Sheet > long Term Debt
6617000
Annuals > 2 > balance Sheet > total Liabilities
13649000
Annuals > 2 > balance Sheet > equity
1841000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-14300000
Annuals > 2 > cash Flow > depreciation
561000
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-6038000
Annuals > 2 > cash Flow > capital Expenditures
412000
Annuals > 2 > cash Flow > cash From Investing
-412000
Annuals > 2 > cash Flow > cash From Financing
7185000
Annuals > 2 > cash Flow > net Change In Cash
338000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
0
Annuals > 2 > ratios > ROE
-776.7517653449213
Annuals > 2 > ratios > ROA
-92.31762427372499
Annuals > 2 > ratios > FCF
-6450000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-0.41626331074540174
Annuals > 2 > health Score
8
Annuals > 3 > quarter
2002-12-31
Annuals > 3 > income Statement > revenue
21184000
Annuals > 3 > income Statement > cost Of Revenue
17322000
Annuals > 3 > income Statement > gross Profit
3862000
Annuals > 3 > income Statement > operating Expenses
25077000
Annuals > 3 > income Statement > operating Income
-3893000
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-30622000
Annuals > 3 > income Statement > net Income
-30988000
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
-
Annuals > 3 > income Statement > income Tax Expense
-352000
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-18.377077039274926
Annuals > 3 > income Statement > total Other Income Expense Net
-26729000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
-
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
-
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
-
Annuals > 3 > balance Sheet > payables
-
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
-
Annuals > 3 > balance Sheet > equity
-
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-30988000
Annuals > 3 > cash Flow > depreciation
936000
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
3239000
Annuals > 3 > cash Flow > capital Expenditures
1966000
Annuals > 3 > cash Flow > cash From Investing
-1966000
Annuals > 3 > cash Flow > cash From Financing
-1735000
Annuals > 3 > cash Flow > net Change In Cash
-534000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
-
Annuals > 3 > ratios > ROA
-
Annuals > 3 > ratios > FCF
1273000
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
0.06009252265861027
Annuals > 3 > health Score
43
Valuation > metrics > PB
0
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
25.070118107197075
Profitability > metrics > ROA
-24.549600624889763
Profitability > metrics > Net Margin
-0.5410974119737865
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-1.7485228951255538
Risk > final Score
23
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.8416869540312186
Liquidity > metrics > Quick Ratio
1.9740799083488472
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
19
Prev Profitabilities > 2
40
Prev Risks > 0
21
Prev Risks > 1
29
Prev Risks > 2
9
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:03:43.558Z
Earnings History > 0 > period
2006-09-30
Earnings History > 0 > report Date
2006-12-04
Earnings History > 0 > date
2006-09-30
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-0.19
Earnings History > 0 > eps Estimate
-0.13
Earnings History > 0 > eps Difference
-0.06
Earnings History > 0 > surprise Percent
-46.1538
Earnings History > 1 > period
2006-06-30
Earnings History > 1 > report Date
2006-08-21
Earnings History > 1 > date
2006-06-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.13
Earnings History > 1 > eps Estimate
-0.09
Earnings History > 1 > eps Difference
-0.04
Earnings History > 1 > surprise Percent
-44.4444
Earnings History > 2 > period
2006-03-31
Earnings History > 2 > report Date
2006-05-17
Earnings History > 2 > date
2006-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.06
Earnings History > 2 > eps Estimate
-0.05
Earnings History > 2 > eps Difference
-0.01
Earnings History > 2 > surprise Percent
-20
Earnings History > 3 > period
2005-09-30
Earnings History > 3 > report Date
2005-11-22
Earnings History > 3 > date
2005-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.1236
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2005-06-30
Earnings History > 4 > report Date
2005-08-19
Earnings History > 4 > date
2005-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.1028
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2005-03-31
Earnings History > 5 > report Date
2005-05-23
Earnings History > 5 > date
2005-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.183
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2004-09-30
Earnings History > 6 > report Date
2004-11-22
Earnings History > 6 > date
2004-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.1116
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2004-06-30
Earnings History > 7 > report Date
2004-08-16
Earnings History > 7 > date
2004-06-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.1055
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2004-03-31
Earnings History > 8 > report Date
2004-05-17
Earnings History > 8 > date
2004-03-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.0668
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2003-09-30
Earnings History > 9 > report Date
2003-11-13
Earnings History > 9 > date
2003-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.0608
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2003-06-30
Earnings History > 10 > report Date
2003-08-19
Earnings History > 10 > date
2003-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0765
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2003-03-31
Earnings History > 11 > report Date
2003-05-19
Earnings History > 11 > date
2003-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.005
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Inyx, Inc., through its wholly-owned subsidiaries, operates as a specialty pharmaceutical company in the United States, Canada, and Europe. It develops and manufactures prescription and over-the-counter pharmaceutical products. The company manufactures hydrocarbon aerosols, a delivery system for dermatological and topical drug applications; metered dose inhalers that are used for respiratory conditions; dry powdered inhalers used for respiratory ailments; metered dose nasal and throat pumps, and sprays; and sterile salines and injectables. It focuses on research and development activities on inhalation-therapy drug delivery devices and inhalation methods, and generic prescription, and over-the-counter aerosol pharmaceutical products for respiratory, allergy, dermatological, and topical and cardiovascular applications. The company's proprietary products under development include generic versions of nonchlorofluorocarbon or hydrofluoroalkane single molecule and combination drug respiratory inhalants, nonCFC propelled oral sprays for cardiovascular ailments, wound irrigation, and cleansing sprays that utilize novel barrier technologies, and anti-inflammatory nasal pumps. It also provides specialty pharmaceutical development and manufacturing consulting services to the international healthcare market. The company was incorporated in 2000 and is based in New York, New York.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2006-09-30)
Health Score
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Inyx Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2006-09-30
EPS Actual
-0.19
EPS Estimate
-0.13
EPS Difference
-0.06
Surprise Percent
-46.1538%
(Last Updated 2006-09-30)
(Last Updated 2006-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2006-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2006-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.